Helen Zhu
Helen Zhu
University of Toronto
Verified email at uhnresearch.ca
Title
Cited by
Cited by
Year
Integrative pathway enrichment analysis of multivariate omics data
M Paczkowska, J Barenboim, N Sintupisut, NS Fox, H Zhu, D Abd-Rabbo, ...
Nature communications 11 (1), 1-16, 2020
432020
Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks
H Zhu, L Uusküla-Reimand, K Isaev, L Wadi, A Alizada, S Shuai, V Huang, ...
Molecular Cell 77 (6), 1307-1321. e10, 2020
252020
The transcriptional landscape of Shh medulloblastoma
P Skowron, H Farooq, FMG Cavalli, AS Morrissy, M Ly, LD Hendrikse, ...
Nature Communications 12 (1), 1-17, 2021
32021
Single-cell mapper (scMappR): using scRNA-seq to infer the cell-type specificities of differentially expressed genes
DJ Sokolowski, M Faykoo-Martinez, L Erdman, H Hou, C Chan, H Zhu, ...
NAR Genomics and Bioinformatics 3 (1), lqab011, 2021
32021
Non-coding mutations reveal cancer driver cistromes in luminal breast cancer
S El Ghamrasni, R Quevedo, J Hawley, P Mazrooei, Y Hanna, I Cirlan, ...
bioRxiv, 2021
2021
MBRS-01. DISSECTING REGULATORS OF THE ABERRANT POST-TRANSCRIPTIONAL LANDSCAPE IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA
M Kameda-Smith, H Zhu, EC Luo, C Venugopal, A Xella, K Brown, R Fox, ...
Neuro-Oncology 22 (Suppl 3), iii399, 2020
2020
MEDU-44. MUSASHI-1 IS A MASTER REGULATOR OF ABERRANT TRANSLATION IN GROUP 3 MEDULLOBLASTOMA
M Kameda-Smith, K Brown, H Zhu, EC Luo, B Yee, S Xing, C Venugopal, ...
Neuro-Oncology 21 (Supplement_2), ii112-ii113, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–7